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a b s t r a c t
We report a case of a female patient, 27 years old, with several episodes of fractures after low 
energy trauma and the first documented episode only to 18 years of age. Extensive research 
has not found the exact etiology of the disease. The orthopedic monitoring has targeted 
prevention and treatment of fractures.
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Introduction
Osteogenesis imperfecta (OI) is a hereditary disorder of 
connective tissue that is characterized by bone fragility with 
clinical manifestations that vary widely, and OI is caused by a 
defect in type 1 collagen.1 The number of individuals with the 
disorder and its incidence are unknown in Brazil, while in the 
United States, the estimated incidence is 1 in 15,000-25,000 
live births.2 
OI encompasses a group of mostly autosomal dominant 
hereditary alterations that are caused by several mutations in 
one of the two genes encoding the alpha chains, i.e., COL1A1 
and COL1A2, of type 1 collagen.1-2 However, in approximately 
10-20% of patients, it is not possible to identify the mutation 
site.3  
Bone fragility is conditioned by the quantity and quality 
of abnormal structural collagen protein. Therefore, bone 
deformities or fractures at minimal trauma are expected in 
patients with the disease. OI presentation varies from the 
lethal forms of intrauterine fractures to late cases in which 
fractures start in adolescence or even adulthood.4 
Due to collagen modifications, other alterations may be 
observed in addition to fractures, such as ligamentous laxity, 
cutis laxa, short stature, dentinogenesis imperfecta, blue or 
gray sclera and, more rarely, alterations in the mitral valve and 
aortic dilation.4,5
Among the differential diagnoses one should exclude 
maltreatment, hypophosphatemia, Paget’s disease, idiopathic 
juvenile osteoporosis, Cushing’s disease, calcium deficiency or 
malabsorption, defects in vitamin D metabolism and Ehlers-
Danlos syndrome types VIIA and VIIB, which are characterized 
by ligamentous laxity and may predispose patients to 
fractures.6  
In 1979, Sillence et al.7 proposed the current classification 
of types I to IV based on clinical findings. Although more 
comprehensive than the classification previously proposed by 
Looser and Seedorf in 1906, as cited in Kim and Gonzales4, 
it does not include the entire spectrum of cases described. 
Recently, types V, VI, VII and VIII2,8 have been included, and 
although they exhibit bone fragility, the defect is not located 
in the collagen gene. 
Case report
The patient was a 27-year-old female pharmacist of Italian 
descent, 162 cm in height and 57 kg in weight, who had been 
undergoing orthopedic monitoring since the age of 18 due to 
episodes of fracture after low-impact events.
The patient had been previously healthy, delivered by 
caesarean section at term due to fetal-pelvic disproportion 
(SIC), with uneventful pre, peri or postpartum. During 
childhood, the patient had no significant morbidities, with a 
report of inguinal hernia repair at 12 months.
She had normal psychomotor development, started walking 
at 1 year of age, micrognathia with orthodontic correction, and 
Fig. 1 - Oblique view x-rays of the left foot; AP and oblique 
view of the right foot showing fractures in different stages of 
consolidation, with no history of major trauma or previous 
complaint of pain.
menarche at 15 years with regular cycles. The family reported 
low-energy traumas characteristic of each age range, without 
the need for medical evaluation. Orthopedic examination 
showed the presence of ligamentous laxity and grayish sclera.
The patient reported that at age 18, during recreational 
activity, there was sudden pain onset in the right foot and 
difficulty walking, and a fracture of the fifth right metatarsal 
was identified. She was treated in the city of Ouro Preto (state of 
Minas Gerais), where treatment by immobilization with plaster 
cast was chosen, which progressed into full consolidation of 
the fracture. At age 22, she had a new episode of sudden pain 
in the same right foot when getting out of bed and was treated 
in the city of Goiania (state of Goias), when a fracture of the 
fourth right metatarsal was identified. She was again treated 
by immobilization with a plaster cast.
At this time, the patient and family returned to Belo 
Horizonte (MG) and sought evaluation at the Department of 
Orthopedics and Traumatology, Hospital Universitario Sao 
Jose at the Faculdade de Ciências Médicas de Minas Gerais, 
where a contralateral foot x-ray was requested and showed 
bone callus formation in contralateral metatarsals, which was 
not associated with trauma or pain (Fig. 1). The immobilization 
treatment was maintained until consolidation and was 
followed by the prescription of custom-made orthopedic 
insoles because the foot scans showed pes cavus varus with 
bilateral adduction of the forefoot, which caused 4th and 5th 
metatarsal overloading. Since then, she has had no complaints 
of pain in the feet and has not had new fractures. 
At age 25, four years after the last visit to the orthopedist, 
she claimed that while dancing, she started with severe pain 
in the anterior right thigh, which continued for 30 days, after 
which she sought orthopedic care in the city of Vicosa (MG). She 
reported that was instructed to rest and return the following 
week. The patient again sought treatment at the Department of 
Orthopedics of HUSJ/FCMMG, where a stress fracture was found 
in the right femur neck (Fullerton and Snowdy types A and B 
in the contralateral neck) (Fig. 2). DHS plate and screw fixation 
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maintained a strict multidisciplinary follow-up; however, the 
underlying pathology has yet to be definitively established. 
Extensive laboratory investigations showed very low 
TSH (0.01 μUI/mL) and normal T4 in December 2009. 
Endocrinological follow-up was maintained, and the patient 
underwent FNA in August 2010 with a diagnosis of toxic 
nodular goiter. She underwent surgical treatment in 2011 and 
receives sodium levothyroxine 88 mcg daily. Other laboratory 
assessments, such as alkaline phosphatase, PTH, vitamin D 
(25-OHD), C-telopeptide, ionic calcium, phosphorus, potassium, 
magnesium, antistreptolysin-O, FAN, and 24-hour calciuria, 
have all been repeated annually from 2009 until 2011 and have 
always been within normal limits. 
Bone densitometry on 9/16/2010 showed a T-score of -2.7 
and Z-score of -2.7, indicating decreased bone mass, with 73% 
of the expected mass for her current age range and weight.
An echocardiogram on 12/4/2008 showed mitral valve 
prolapse associated with mild mitral regurgitation, left-to-
right interatrial shunt (patent foramen ovale) and mild aortic 
dilation.
An ECG performed in 2009 at the time of surgical risk 
showed atrial arrhythmia. The patient uses metoprolol daily, 
with rhythm normalization since then.
A genetic study performed on 12/15/2010 did not 
demonstrate consanguinity between parents and a healthy 
10-year younger brother, who were negative for OI or other 
genetic more common disorders. It was suggested by clinical 
examination that the patient might have Ehlers-Danlos 
syndrome, one possible case of mutation due to autosomal 
dominant inheritance, though the parents do not have the 
same characteristics. It is important to note that there is no 
confirmatory test of diagnostic proof.   
Discussion
This is an atypical case in the daily practice of an orthopedic 
consultation office. Despite the suggestion made by the 
was performed to the right, and two large-fragment cannulated 
screws were used in the left neck, anticipating the possibility of 
progression of fracture trace. Investigative workup was started 
to screen for inborn errors of metabolism or osteogenesis 
imperfecta (OI), which was performed via endocrinological, 
cardiology and genetics investigation. 
In November 2011, at age 27, she started having pain in the 
anterior aspect of the left thigh, similar to the contralateral side 
three years before. She came to the department, and diastasis 
in the neck of the left femur was identified, with a type A trace 
of Fullerton and Snowdy for stress fractures of the neck of the 
femur, which had been preventively fixed two years previously, 
when she had a type B trace of Fullerton and Snowdy (Fig. 3). 
Due to the patient’s good sociocultural level and emotional 
fragility to undergo a new surgical procedure, it was decided 
to postpone operative treatment and remove the load from 
the left leg.
The patient has shown good evolution towards consolidation 
without pain, as reported in March 2012 (Fig. 4). She has 
Fig. 2 - AP view x-ray of coxofemoral joint; the arrows show 
signs of stress fractures of the femoral neck.
Fig. 3 - Sign of new stress fracture in the left femur neck, 
despite preventive fixation two years prior to the complaint 
of hip pain.
Fig. 4 - AP view x-ray of the left coxofemoral joint showing 
fracture healing after conservative treatment.
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geneticist that the patient might have Ehlers-Danlos 
syndrome, which cannot be ruled out, the patient meets 
the epistemological criteria for OI classification, although 
laboratory confirmation is not possible. Genetically, one 
cannot attest to the case. This case may resemble the new 
types described by Glorieux et al. in Canada. The patient 
currently maintains the regular use of metoprolol, injectable 
teriparatide and risedronate, in addition to calcium and 
vitamin D supplementation. Until a new treatment is available, 
a regular multidisciplinary follow-up will be maintained. It is 
the orthopedic team’s objective to prevent further fractures 
or manage them so the patient has quality of life and a daily 
routine as close to normal as possible.
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